Similar articles

• [Glycosylated hemoglobin and clinical evaluation of the degree of diabetes control. Relation to blood sugar, blood cholesterol, blood triglycerides, and the duration of diabetes and retinopathy. Study of 85 diabetic children and adolescents].

  Dorchy H, Despontin M, Haumont D, Toussaint D, De Vroede M, Loeb H. Dorchy H, et al. Sem Hop. 1982 Dec 23;58(47):2773-80. Sem Hop. 1982. PMID: 6301021 French.
• Long-term blood glucose control and diabetic retinopathy.

  Finotti P, Piccoli A. Finotti P, et al. Lancet. 1990 Jan 13;335(8681):107-8. doi: 10.1016/0140-6736(90)90569-q. Lancet. 1990. PMID: 1967384 No abstract available.
• Glycosylated hemoglobin (Hb AI) as an indicator of therapy effects in different clinical types of diabetes.

  Czech A, Tatoń J. Czech A, et al. J Chronic Dis. 1983;36(11):803-10. doi: 10.1016/0021-9681(83)90072-3. J Chronic Dis. 1983. PMID: 6643647
• Retinopathy in patients with type 1 diabetes 4 years after intensive therapy.

  Bressler SB, Bressler NM. Bressler SB, et al. Arch Ophthalmol. 2000 Jul;118(7):984-5. Arch Ophthalmol. 2000. PMID: 10910526 Review. No abstract available.
• Blood glucose control and microvascular complications--what do we do now?

  Dahl-Jørgensen K, Brinchmann-Hansen O, Bangstad HJ, Hanssen KF. Dahl-Jørgensen K, et al. Diabetologia. 1994 Dec;37(12):1172-7. doi: 10.1007/BF00399789. Diabetologia. 1994. PMID: 7895945 Review. No abstract available.